FDA Recalls Faulty Insulin Pump App After Hundreds Injured

Over 224 diabetes patients suffered due to a software glitch in Tandem Diabetes Care's t:connect app, prompting an urgent recall.

The t:connect app issue led to unexpected insulin pump shutdowns, risking severe hyperglycemia and ketoacidosis.
FDA classified the recall as Class I, indicating a risk of serious injury or death.
Affected users are urged to update their app to version 2.7.1 to prevent further incidents.
No fatalities have been reported, but the software flaw has caused significant concern among patients.
Tandem Diabetes Care has issued urgent updates and instructions to mitigate the risk to users.